Phebra Acquires Equity Stake in UK Specialty Hospital Pharma Company Flexipharm Austrading

– Phebra takes part ownership of Flexipharm Austrading through share purchase

– Builds on Phebra’s Existing UK Distribution Agreement

– Strengthens Phebra’s Presence in UK and Europe

SYDNEY and BOURNE END, EnglandNov. 3, 2021 /PRNewswire/ — Leading Australian pharmaceutical group Phebra Holdings (‘Phebra’) is pleased to announce that it has completed a share purchase agreement with the UK hospital specialty pharmaceutical company Flexipharm Austrading Limited (‘FAL’).

Read more…